QT Imaging (NASDAQ:QTI) versus BioSig Technologies (NASDAQ:BSGM) Financial Analysis

BioSig Technologies (NASDAQ:BSGM) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation.

Earnings & Valuation

This table compares BioSig Technologies and QT Imaging”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioSig Technologies	$20,000.00	887.86	-$29.04 million	N/A	N/A
QT Imaging	$4.00 million	2.71	-$4.03 million	N/A	N/A

QT Imaging has higher revenue and earnings than BioSig Technologies.

Institutional and Insider Ownership

7.2% of BioSig Technologies shares are held by institutional investors. Comparatively, 24.2% of QT Imaging shares are held by institutional investors. 17.0% of BioSig Technologies shares are held by insiders. Comparatively, 75.4% of QT Imaging shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares BioSig Technologies and QT Imaging’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
BioSig Technologies	-44,832.50%	N/A	-776.49%
QT Imaging	N/A	N/A	-65.94%

Risk & Volatility

BioSig Technologies has a beta of 0.56, suggesting that its share price is 44% less volatile than the S&P 500. Comparatively, QT Imaging has a beta of -0.2, suggesting that its share price is 120% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings for BioSig Technologies and QT Imaging, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BioSig Technologies	0	0	1	0	3.00
QT Imaging	0	0	0	0	0.00

BioSig Technologies presently has a consensus target price of $2.75, indicating a potential upside of 166.99%. Given BioSig Technologies’ stronger consensus rating and higher possible upside, analysts plainly believe BioSig Technologies is more favorable than QT Imaging.

Summary

QT Imaging beats BioSig Technologies on 6 of the 11 factors compared between the two stocks.

About BioSig Technologies

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

About QT Imaging

QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.